At first, Krista Easom figured the little red bump on her foot was nothing more than a blister.
It didn’t hurt, but after a couple months, it didn’t go away either.
She booked an appointment with a dermatologist to have it removed. She wasn’t worried. Easom, a 24-year-old law school student from New Jersey, was healthy, had no family history of cancer and was getting ready to enjoy some time in her newly adopted city of Chicago.
That’s when she received the results from her dermatologist, who removed a part of the blister and had it tested.
It turns out that little red bump was malignant melanoma, the leading cause of skin cancer death in the United States. It’s a cancer that kills one person every hour, which translates to more than 8,700 Americans each year.
Further tests revealed that Easom’s melanoma had spread to her lymph nodes, which meant she needed a lymphadenectomy to have them removed. This major surgery includes a five-day stay in the hospital followed by an extensive recovery. About half of the patients who undergo this procedure suffer from wound infections because of the 12-inch incision’s hip-to-thigh location.
Easom and her family looked into her options and she was referred to Northwestern Medicine® surgical oncologists Jeffery D. Wayne, MD and Karl Bilimoria, MD, two of the very few surgeons in the country using a minimally invasive procedure to remove groin lymph nodes. This laparoscopic procedure may drastically reduce the recovery rate and chance of infection for patients like Easom.
“Only a handful of surgeons in the country are doing this and it makes a world of difference to the patient,” said Bilimoria, a surgical oncologist at Northwestern Memorial Hospital and an assistant professor of surgery at Northwestern University Feinberg School of Medicine. “Instead of a 12-inch scar, this laparoscopic procedure has only three very small incisions that total less than one inch. Because these incisions are so small, the chance of infection is far less. Instead of a five-day stay in the hospital, Krista went home the day after her surgery.”
Lymph nodes are the most frequent site of the spread of metastatic melanoma and surgically removing them is the only potential for a cure, Wayne said.
“Surgery is the only way to make sure we get all of the cancer,” Wayne said. “We want Krista to move on with her life. The minimally-invasive procedure was by far, the quickest and safest way for her to do that.”
Just a few weeks post-surgery, Easom is already on her way. She will have regular check-ups for awhile but her CT scans and blood tests show that the surgery successfully removed all of her cancer. Easom is participating in a national clinical trial to see if this minimally invasive procedure can help other melanoma patients.
The Latest on: Melanoma
Four Subtypes Of Melanoma Found
on April 20, 2018 at 4:59 pm
It has been found by researchers at UCLA that melanoma cells can be divided into 4 distinct subtypes according to differentiation stage, and that cell subtypes that de-differentiated showed sensitivity to a type of self inflicted cell death. Melanoma is a ... […]
PAs may have lower diagnostic accuracy for melanoma
on April 20, 2018 at 11:24 am
(HealthDay)—Physician assistants (PAs) perform more skin biopsies per case of skin cancer diagnosed and diagnose fewer melanomas in situ than dermatologists, according to a study published online April 18 in JAMA Dermatology. Alyce M. Anderson, Ph.D ... […]
Amateurs Like Us: Melanoma Can't Stop Nick Hinze From Making His Mark On Eventing (Views: 1489)
on April 20, 2018 at 8:51 am
Uncertainty filled the air as Nicolas “Nick” Hinze picked at his breakfast. The plan—one he’d executed many times before—was to make the six-hour trek from the home he shares with wife Tracy Hinze in Bedford, Virginia, to Aiken, South Carolina ... […]
Global Melanoma Market Report 2018 - Anticipated to Reach a Market Value of $14 Billion by 2024
on April 20, 2018 at 8:25 am
The "Global Malignant Melanoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024" report has been added to ResearchAndMarkets.com's offering. The global melanoma market is anticipated to expand in value from US$ close to 5 Billion in 2016 to an ... […]
TLR9 Agonist May Reverse Resistance to Immune Checkpoint Inhibition in Melanoma
on April 20, 2018 at 7:23 am
Treatment with the intratumoral Toll-like receptor 9 (TLR9) agonist CMP-001 appeared to potentially reverse resistance to immune checkpoint inhibition in patients with metastatic melanoma, inducing responses to pembrolizumab in some patients. “There are ... […]
Global Malignant Melanoma Drug Market Report 2018: Dosage, Price & Clinical Pipeline Outlook 2024
on April 20, 2018 at 12:17 am
The global melanoma market is anticipated to expand in value from US$ close to 5 Billion in 2016 to an estimated US$ 14 billion by 2024, representing a robust Compound Annual Growth Rate (CAGR) of 12%. The advancement in research and development of ... […]
Drug combination targeting HSP90 and BRAF is safe and effective in advanced melanoma
on April 19, 2018 at 10:01 am
Patients with advanced or metastatic melanoma have been able to live longer cancer-free lives because of several new therapies approved over the last decade, such as BRAF and MEK inhibitors. However, despite the success of these targeted agents, most ... […]
Drug May Reverse Anti-PD-1 Resistance in Melanoma
on April 19, 2018 at 7:44 am
Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. Melanoma that developed resistance to anti-PD-1 therapy started ... […]
Spouses can boost early detection for melanoma patients
on April 18, 2018 at 5:21 pm
CHICAGO — There’s an extra bonus to marriage for melanoma patients: They tend to be diagnosed in earlier more treatable stages than patients who are unmarried, widowed or divorced, a new study says. Spouses may be apt to notice suspicious moles on ... […]
Married People Less Likely to Die From Melanoma
on April 18, 2018 at 11:37 am
Married people are more likely than the unmarried to get timely diagnosis and treatment for malignant skin cancer. Early detection of melanoma, the deadliest form of skin cancer, is essential to effective treatment. The five-year survival rate for stage 1 ... […]
via Google News and Bing News